title: Hypofractionated radiation therapy in the treatment of early-stage breast cancer.
abstract: Hypofractionated radiation refers to the use of fewer, larger-dose radiation treatments that are usually given over a shorter time period compared to conventional radiation fraction sizes. Randomized trials of hypofractionated whole breast irradiation (WBI) have demonstrated comparable outcomes as conventional fractionation. For a higher-risk population for local recurrence, a phase 3 trial by the Radiation Therapy Oncology Group (RTOG) is currently studying hypofractionated WBI with a concurrent tumor bed boost over 3 weeks. Accelerated partial breast irradiation limits radiation to the region of the tumor bed for 1-3 weeks and is the subject of an ongoing randomized trial by the National Surgical Breast and Bowel Project and RTOG. Questions remain for hypofractionation about optimal patient selection, radiation techniques, and the risk of late toxicity. But results from current trials could make hypofractionation more widely accepted for patients with early-stage breast cancer.
authors.affiliation: Department of Radiation Oncology, Perelman Center for Advanced Medicine, TRC 4 West, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA. gary.freedman@uphs.upenn.edu
authors.forename: Gary M
authors.initials: GM
authors.lastname: Freedman
mesh_terms: D001943:Breast Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D019583:Dose Fractionation, Radiation; D005260:Female; D006801:Humans; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic
references.citation: J Clin Oncol. 2007 Aug 1;25(22):3259-65
references.pmid: 17577015
references.citation: Am J Surg. 2007 Oct;194(4):456-62
references.pmid: 17826055
references.citation: Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):689-94
references.pmid: 19362779
references.citation: N Engl J Med. 2002 Oct 17;347(16):1233-41
references.pmid: 12393820
references.citation: Lancet. 2005 Dec 17;366(9503):2087-106
references.pmid: 16360786
references.citation: Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1120-7
references.pmid: 19910132
references.citation: J Clin Oncol. 2005 Mar 10;23(8):1726-35
references.pmid: 15755981
references.citation: Ann Oncol. 2001 Jul;12(7):997-1003
references.pmid: 11521809
references.citation: Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):808-17
references.pmid: 20472364
references.citation: Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1328-36
references.pmid: 15817334
references.citation: J Surg Oncol. 2011 Mar 15;103(4):362-8
references.pmid: 21337572
references.citation: J Clin Oncol. 2006 May 1;24(13):2028-37
references.pmid: 16648502
references.citation: J Clin Oncol. 2009 May 20;27(15):2466-73
references.pmid: 19349544
references.citation: Radiother Oncol. 2005 Apr;75(1):9-17
references.pmid: 15878095
references.citation: Lancet Oncol. 2006 Jun;7(6):467-71
references.pmid: 16750496
references.citation: Int J Radiat Oncol Biol Phys. 1991 Jul;21(2):331-8
references.pmid: 2061109
references.citation: Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):987-1001
references.pmid: 19545784
references.citation: Radiother Oncol. 2010 Mar;94(3):264-73
references.pmid: 20181402
references.citation: Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):347-53
references.pmid: 17379430
references.citation: Radiother Oncol. 2010 Mar;94(3):274-9
references.pmid: 20181401
references.citation: Lancet. 2008 Mar 29;371(9618):1098-107
references.pmid: 18355913
references.citation: Lancet Oncol. 2008 Apr;9(4):331-41
references.pmid: 18356109
references.citation: J Clin Oncol. 2000 Apr;18(8):1668-75
references.pmid: 10764427
references.citation: N Engl J Med. 2010 Feb 11;362(6):513-20
references.pmid: 20147717
references.citation: Am J Clin Oncol. 2006 Feb;29(1):66-70
references.pmid: 16462506
references.citation: J Clin Oncol. 1997 Mar;15(3):963-8
references.pmid: 9060534
references.citation: Am J Surg. 2000 Oct;180(4):299-304
references.pmid: 11113440
references.citation: Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):489-95
references.pmid: 16246495
references.citation: J Clin Oncol. 2007 Jun 1;25(16):2236-42
references.pmid: 17470849
references.citation: Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):467-73
references.pmid: 18294778
references.citation: Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1281-9
references.pmid: 11121624
references.citation: Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):71-8
references.pmid: 19409733
references.citation: Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):694-702
references.pmid: 17531400
references.citation: Brachytherapy. 2007 Oct-Dec;6(4):286-92
references.pmid: 17991625
references.citation: Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):354-8
references.pmid: 17383829
references.citation: Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):991-7
references.pmid: 19515514
references.citation: Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):365-73
references.pmid: 15667954
references.citation: N Engl J Med. 2002 Oct 17;347(16):1227-32
references.pmid: 12393819
references.citation: Radiother Oncol. 2011 Aug;100(2):210-4
references.pmid: 21497927
references.citation: Cancer. 1996 Mar 15;77(6):1094-100
references.pmid: 8635129
references.citation: Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1307-10
references.pmid: 11121627
references.citation: Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1124-30
references.pmid: 17967306
references.citation: J Clin Oncol. 2008 May 1;26(13):2085-92
references.pmid: 18285602